Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1996-12-26
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0033-8419
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
201
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
879-80
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8939248-Contrast Media,
pubmed-meshheading:8939248-Diabetes Mellitus,
pubmed-meshheading:8939248-Diabetic Ketoacidosis,
pubmed-meshheading:8939248-Diabetic Nephropathies,
pubmed-meshheading:8939248-Humans,
pubmed-meshheading:8939248-Hypoglycemic Agents,
pubmed-meshheading:8939248-Metformin
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Metformin and contrast media: genuine risk or witch hunt?
|
| pubmed:publicationType |
Letter,
Comment
|